<code id='DA8B5A3221'></code><style id='DA8B5A3221'></style>
    • <acronym id='DA8B5A3221'></acronym>
      <center id='DA8B5A3221'><center id='DA8B5A3221'><tfoot id='DA8B5A3221'></tfoot></center><abbr id='DA8B5A3221'><dir id='DA8B5A3221'><tfoot id='DA8B5A3221'></tfoot><noframes id='DA8B5A3221'>

    • <optgroup id='DA8B5A3221'><strike id='DA8B5A3221'><sup id='DA8B5A3221'></sup></strike><code id='DA8B5A3221'></code></optgroup>
        1. <b id='DA8B5A3221'><label id='DA8B5A3221'><select id='DA8B5A3221'><dt id='DA8B5A3221'><span id='DA8B5A3221'></span></dt></select></label></b><u id='DA8B5A3221'></u>
          <i id='DA8B5A3221'><strike id='DA8B5A3221'><tt id='DA8B5A3221'><pre id='DA8B5A3221'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:836
          Sammy Kimball for STAT

          Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

          advertisement

          For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          focus

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          'Little Tech' descents on D.C., wanting a say in how AI is regulated
          'Little Tech' descents on D.C., wanting a say in how AI is regulated

          GarryTan,CEOofYCombinatorSebDaly/WebSummiWASHINGTON—InSanFrancisco,YCombinator’sfirebrandchiefexecut

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Medicare Advantage today, explained in one chart

          PabloMartinezMonsivais/APYou’rereadingthewebversionofHealthCareInc., STAT’sweeklynewsletter followin